CHRNA7 and systemic lupus erythematosus: Since α7-nAChRs are essential in the anti-inflammatory response within the cholinergic anti-inflammatory pathway, we hypothesize that systemic administration of α7 ligands will be a successful therapeutic strategy in SLE by reducing peripheral inflammation and improving behavior in a mouse model of SLE.